The Ensuring Pathways to Innovative Cures Act would extend the time Medicare can negotiate and set prices for small molecule ...

President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut ...

The generic drug manufacturer was linked to the death of eight people last year, and was responsible for an outsized share of recalls for pills that didn’t dissolve properly and could harm people.

Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction Act (IRA), former President Biden's signature ...

Just before the inauguration, the outgoing Biden administration announced 15 new medications that'll be subject to government price negotiations under the ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...

CMS should monitor the effect on Medicare standalone prescription drug plans of changes in how the drug costs of high-cost ...

Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

As a drugmaker depending heavily on sales of both branded and non-branded products, Teva has said that it is uniquely affected by how medicines are selected for the Medicare drug price negotiation | ...

Joe Biden’s presidency is mercifully over. However, his damaging policies are still with us — as a recent announcement from ...

Republicans eager to offset the cost of cutting taxes may see lower Medicare spending on outpatient care as a source of budgetary savings.